12 June 2015
(Oxford, UK, 12 June 2015) Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune disease, is pleased to announce that it won the “Emerging Star of the Year Award” at last night’s European Mediscience Awards 2015.
Dr Eliot Forster, Chief Executive Officer of Immunocore, commented: “We are delighted to have won the Emerging Star Award. It is a great privilege, particularly given the calibre of the other nominees in this category. The past year has been transformational for Immunocore as we continued to make significant progress in the clinic with our lead candidate, IMCgp100, in advanced melanoma. Our partnerships with AstraZeneca, Genentech, GSK and Lilly are progressing well and we are rapidly expanding our wholly-owned portfolio of ImmTACs.”
The European Mediscience Awards, sponsored by Kempen & Co, is the largest annual gathering of private and publicly quoted healthcare, biotech and life sciences companies in Europe. It celebrates the best in the sector and highlights the achievements of individuals and companies. The event recognizes the importance of the capital markets to fund growth and innovation.
Please click on the link below to download the full Press Release:
Immunocore Wins Emerging Star of the Year Award at the European Mediscience Awards 2015
